SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML

被引：75

作者：

Laborde, R. R. ^{[1
]}

Patnaik, M. M. ^{[1
]}

Lasho, T. L. ^{[1
]}

Finke, C. M. ^{[1
]}

Hanson, C. A. ^{[2
]}

Knudson, R. A. ^{[3
]}

Ketterling, R. P. ^{[3
]}

Pardanani, A. ^{[1
]}

Tefferi, A. ^{[1
]}

机构：

[1] Mayo Clin, Dept Med, Div Hematol, Rochester, MN 55905 USA

[2] Mayo Clin, Dept Lab Med, Div Hematopathol, Rochester, MN USA

[3] Mayo Clin, Dept Lab Med, Cytogenet Div, Rochester, MN USA

来源：

LEUKEMIA | 2013年 / 27卷 / 10期

关键词：

SCHINZEL-GIEDION SYNDROME; ACUTE MYELOID-LEUKEMIA; MODEL;

D O I：

10.1038/leu.2013.97

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2100 / 2102

页数：4

共 12 条

[1] SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia [J].

Albano, Francesco ;

Anelli, Luisa ;

Zagaria, Antonella ;

Coccaro, Nicoletta ;

Casieri, Paola ;

Minervini, Angela ;

Specchia, Giorgina .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5

[2] SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia [J].

Cristobal, Ion ;

Blanco, Francisco J. ;

Garcia-Orti, Laura ;

Marcotegui, Nerea ;

Vicente, Carmen ;

Rifon, Jose ;

Novo, Francisco J. ;

Bandres, Eva ;

Calasanz, Maria J. ;

Bernabeu, Carmelo ;

Odero, Maria D. .

BLOOD, 2010, 115 (03) :615-625

[3] SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias [J].

Damm, F. ;

Itzykson, R. ;

Kosmider, O. ;

Droin, N. ;

Renneville, A. ;

Chesnais, V. ;

Gelsi-Boyer, V. ;

de Botton, S. ;

Vey, N. ;

Preudhomme, C. ;

Clavert, A. ;

Delabesse, E. ;

Park, S. ;

Birnbaum, D. ;

Fontenay, M. ;

Bernard, O. A. ;

Solary, E. .

LEUKEMIA, 2013, 27 (06) :1401-1403

[4] Reduced expression by SETBP1 haploinsufficiency causes developmental and expressive language delay indicating a phenotype distinct from Schinzel-Giedion syndrome [J].

Filges, Isabel ;

Shimojima, Keiko ;

Okamoto, Nobuhiko ;

Roethlisberger, Benno ;

Weber, Peter ;

Huber, Andreas R. ;

Nishizawa, Tsutomu ;

Datta, Alexandre N. ;

Miny, Peter ;

Yamamoto, Toshiyuki .

JOURNAL OF MEDICAL GENETICS, 2011, 48 (02) :117-122

[5] DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status [J].

Gangat, Naseema ;

Caramazza, Domenica ;

Vaidya, Rakhee ;

George, Geeta ;

Begna, Kebede ;

Schwager, Susan ;

Van Dyke, Daniel ;

Hanson, Curtis ;

Wu, Wenting ;

Pardanani, Animesh ;

Cervantes, Francisco ;

Passamonti, Francesco ;

Tefferi, Ayalew .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04) :392-397

[6] De novo mutations of SETBP1 cause Schinzel-Giedion syndrome [J].

Hoischen, Alexander ;

van Bon, Bregje W. M. ;

Gilissen, Christian ;

Arts, Peer ;

van Lier, Bart ;

Steehouwer, Marloes ;

de Vries, Petra ;

de Reuver, Rick ;

Wieskamp, Nienke ;

Mortier, Geert ;

Devriendt, Koen ;

Amorim, Marta Z. ;

Revencu, Nicole ;

Kidd, Alexa ;

Barbosa, Mafalda ;

Turner, Anne ;

Smith, Janine ;

Oley, Christina ;

Henderson, Alex ;

Hayes, Ian M. ;

Thompson, Elizabeth M. ;

Brunner, Han G. ;

de Vries, Bert B. A. ;

Veltman, Joris A. .

NATURE GENETICS, 2010, 42 (06) :483-485

[7] Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System [J].

Kantarjian, Hagop ;

O'Brien, Susan ;

Ravandi, Farhad ;

Cortes, Jorge ;

Shan, Jianqin ;

Bennett, John M. ;

List, Alan ;

Fenaux, Pierre ;

Sanz, Guillermo ;

Issa, Jean-Pierre ;

Freireich, Emil J. ;

Garcia-Manero, Guillermo .

CANCER, 2008, 113 (06) :1351-1361

[8] Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10 [J].

Oakley, Kevin ;

Han, Yufen ;

Vishwakarma, Bandana A. ;

Chu, Su ;

Bhatia, Ravi ;

Gudmundsson, Kristbjorn O. ;

Keller, Jonathan ;

Chen, Xiongfong ;

Vasko, Vasyl ;

Jenkins, Nancy A. ;

Copeland, Neal G. ;

Du, Yang .

BLOOD, 2012, 119 (25) :6099-6108

[9] Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients [J].

Onida, F ;

Kantarjian, HM ;

Smith, TL ;

Ball, G ;

Keating, MJ ;

Estey, EH ;

Glassman, AB ;

Albitar, M ;

Kwari, MI ;

Beran, M .

BLOOD, 2002, 99 (03) :840-849

[10] Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes [J].

Patnaik, M. M. ;

Padron, E. ;

LaBorde, R. R. ;

Lasho, T. L. ;

Finke, C. M. ;

Hanson, C. A. ;

Hodnefield, J. M. ;

Knudson, R. A. ;

Ketterling, R. P. ;

Al-kali, A. ;

Pardanani, A. ;

Ali, N. A. ;

Komroji, R. S. ;

Tefferi, A. .

LEUKEMIA, 2013, 27 (07) :1504-1510

← 1 2 →